A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)

Trial Identifier: D7280C00001
Sponsor: AstraZeneca
Start Date: July 2026
Primary Completion Date: October 2026
Study Completion Date: September 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Long Beach, CA, US, 90815
US, CA Rolling Hills Estates, CA, US, 90274
US, IL Chicago, IL, US, 60640
US, KS Lenexa, KS, US, 66219
US, MO Kansas City, MO, US, 64114
US, NE Omaha, NE, US, 68134